Loading…
II

Ilan Irony

FDA
Deputy Director, DCEPT, OTAT, CBER
After training at UCSF and NIH and years of practice in Internal Medicine and Endocrinology, Dr. Irony joined FDA CBER in 2000 as a clinical reviewer. He also worked in the Endocrine Division in CDER as a reviewer and team leader. In 2011, he returned to CBER as the branch chief, and recently became Deputy Director in the Division of Clinical Evaluation and Pharmacology / Toxicology in the Office of Tissues and Advanced Therapies.

My Speakers Sessions

Monday, June 19
 

11:00am

 
Wednesday, June 21
 

10:30am